Literature DB >> 27758973

Evolution of Chagas' disease in Brazil. Epidemiological perspective and challenges for the future: a critical review.

Rafael Bello Corassa1, Carmen Aceijas2, Paula Aryane Brito Alves1, Hemda Garelick3.   

Abstract

AIMS: This article aimed to provide a critical review of the evolution of Chagas' disease (ChD) in Brazil, its magnitude, historical development and management, and challenges for the future.
METHODS: A literature search was performed using PubMed, SciELO and Google Scholar and throughout collected articles' references. Narrative analysis was structured around five main themes identified: vector transmission, control programme, transfusion, oral and congenital transmission.
RESULTS: In Brazil, the Chagas' Disease Control Programme was fully implemented in the 1980s, when it reached practically all the endemic areas, and in 1991, the Southern Cone Initiative was created, aiming to control the disease transmission through eliminating the Triatoma infestans and controlling blood banks. As a result, the prevalence of chagasic donors in blood banks reduced from 4.4% in the 1980s to 0.2% in 2005. In 2006, Pan American Health Organization (PAHO) certified the interruption of transmission of ChD through this vector in Brazil. However, there are still challenges, such as the domiciliation of new vector species, the need for medical care of the infected individuals, the prevention of alternative mechanisms of transmission, the loss of political concern regarding the disease and the weakening of the control programme.
CONCLUSION: Despite the progress towards control, there are still many challenges ahead to maintain and expand such control and minimise the risk of re-emergence.

Entities:  

Keywords:  Brazil epidemiology; Chagas disease; Trypanosoma cruzi; epidemiologic surveillance; neglected tropical diseases; public health

Mesh:

Year:  2016        PMID: 27758973     DOI: 10.1177/1757913916671160

Source DB:  PubMed          Journal:  Perspect Public Health        ISSN: 1757-9147


  4 in total

1.  Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Authors:  Juan Carlos Villar; Víctor Mauricio Herrera; Juan Guillermo Pérez Carreño; Eliana Váquiro Herrera; Yeny Zulay Castellanos Domínguez; Skarlet Marcell Vásquez; Zulma Milena Cucunubá; Nilda Graciela Prado; Yolanda Hernández
Journal:  Trials       Date:  2019-07-15       Impact factor: 2.279

2.  Editorial: Innovative Therapeutic and Immunomodulatory Strategies for Protozoan Infections.

Authors:  Jorge Enrique Gómez Marín; Kamal El Bissati
Journal:  Front Cell Infect Microbiol       Date:  2019-08-09       Impact factor: 5.293

3.  High incidence of Trypanosoma cruzi infections in dogs directly detected through longitudinal tracking at 10 multi-dog kennels, Texas, USA.

Authors:  Rachel E Busselman; Alyssa C Meyers; Italo B Zecca; Lisa D Auckland; Andres H Castro; Rebecca E Dowd; Rachel Curtis-Robles; Carolyn L Hodo; Ashley B Saunders; Sarah A Hamer
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10

4.  Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis.

Authors:  Antônio da Silva Menezes Junior; Cynthia Caetano Lopes; Patrícia Freire Cavalcante; Edésio Martins
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jan-Feb
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.